Program
tafamidis
Also written as “Tafamidis”, “Fx-1006A” and “Tafamidis 61 mg free acid capsule (Reference)”.
Its studies are mostly in Amyloid Neuropathies, Familial · Cardiomyopathies · Amyloidosis, led by Pfizer.
Furthest: phase 4, since Mar 10, 202129 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Pfizer | 290 open or running | phase 4since Mar 10, 2021 | Dec 6, 2006 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 14 studies since Dec 6, 2006.
- Feb 29, 2016Phase 1 study in HealthyNCT02697864 · 12 enrolled · Belgium
- Apr 18, 2016Phase 1 study in HealthyNCT02746926 · 12 enrolled · United States
- Jun 1, 2016Phase 3 study in Amyloid Neuropathies, FamilialNCT02791230 · 1,733 enrolled · United States, Argentina, Australia and more
- Aug 28, 2017Phase 1 study in HealthyNCT03266705 · 30 enrolled · Belgium
- Sep 5, 2017Phase 1 study in HealthyNCT03280173 · 18 enrolled · Belgium
- Aug 23, 2018Phase 1 study in Healthy VolunteersNCT03662191 · 9 enrolled · Belgium
- Jan 31, 2020Phase 1 study in Healthy VolunteersNCT04253353 · 12 enrolled · Belgium
- Sep 23, 2020Phase 1 study in HealthyNCT04575116 · 23 enrolled · United States
- Mar 10, 20212 phase 4 studiesNCT04814186, NCT04828993
- Aug 10, 2022Phase 1 study in HealthyNCT05498701 · 22 enrolled · Canada
- Feb 15, 2024Phase 1 study in HealthyNCT06273839 · 12 enrolled · Belgium
- Nov 22, 2024Phase 1 study in HealthyNCT06705569 · 22 enrolled · Belgium
- Mar 10, 2026Phase 1 study in HealthyNCT07470866 · 24 enrolled · Belgium
- May 8, 2026Phase 1 study in Healthy AdultsNCT07587697 · 30 enrolled · Japan
TargetBeta
TTR →read by rule
“Transthyretin stabiliser; Transthyretin stabiliser”ChEMBL 37, by rule
Other programs on TTR
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| acoramidisrule | BridgeBio | phase 4 | 15 |
| coramitug | Novo Nordisk | phase 3 | 3 |
| coramitug | Novo Nordisk | phase 1 | 2 |
Studies
All 29 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07587697Healthy Adults · Japan | 1 | Completed | Aug 3, 2026 | 30 |
| NCT07470866Healthy · Belgium | 1 | Terminated | May 12, 2026 | 24 |
| NCT06705569Healthy · Belgium | 1 | Completed | Apr 4, 2025 | 22 |
| NCT06273839Healthy · Belgium | 1 | Completed | May 27, 2024 | 12 |
| NCT05498701Healthy · Canada | 1 | Completed | Dec 18, 2022 | 22 |
| NCT04828993Amyloid Neuropathies, Familial · China | 4 | Completed | Feb 12, 2023 | 15 |
| NCT04814186Transthyretin Amyloid Cardiomyopathy · China | 4 | Completed | Oct 16, 2023 | 53 |
| NCT04575116Healthy · United States | 1 | Completed | Feb 23, 2021 | 23 |
| NCT04253353Healthy Volunteers · Belgium | 1 | Completed | Aug 10, 2020 | 12 |
| NCT03662191Healthy Volunteers · Belgium | 1 | Completed | Jan 10, 2019 | 9 |
| NCT03280173Healthy · Belgium | 1 | Completed | Feb 23, 2018 | 18 |
| NCT03266705Healthy · Belgium | 1 | Completed | Feb 15, 2018 | 30 |
| NCT02791230Amyloid Neuropathies, Familial · United States, Argentina, Australia and more | 3 | Completed | Oct 26, 2023 | 1,733 |
| NCT02746926Healthy · United States | 1 | Completed | Jul 15, 2016 | 12 |
| NCT02697864Healthy · Belgium | 1 | Completed | Jun 2016 | 12 |
| NCT02534740Healthy · Belgium | 1 | Completed | Dec 2015 | 18 |
| NCT02406560Healthy Volunteers · Belgium | 1 | Completed | Jun 2015 | 12 |
| NCT02217813Healthy Volunteers · Belgium | 1 | Completed | Nov 2014 | 26 |
| NCT02189330Healthy Volunteers · Belgium | 1 | Completed | Jul 2014 | 24 |
| NCT01994889Amyloid Neuropathies, Familial · United States, Belgium, Brazil and more | 3 | Completed | Feb 7, 2018 | 441 |
| NCT01655511TTR Cardiomyopathy · Singapore | 1 | Completed | Sep 2012 | 9 |
| NCT01435655Transthyretin Familial Amyloid Polyneuropathy · Japan | 3 | Completed | Feb 2014 | 10 |
| NCT01358565Mild Hepatic Dysfunction · South Africa | 1 | Completed | Apr 2011 | 16 |
| NCT00935012Cardiomyopathies · United States | 3 | Completed | Nov 20, 2019 | 31 |
| NCT00925002ATTR-PN · United States, Argentina, Brazil and more | 3 | Completed | Jul 8, 2020 | 93 |
| NCT00791492Amyloid Neuropathies, Familial · Argentina, Brazil, France and more | 3 | Completed | Aug 2008 | 86 |
| NCT00694161Cardiomyopathies · United States | 2 | Completed | Jan 2010 | 35 |
| NCT00630864Amyloidosis · United States, France, Germany and more | 2 | Completed | Jan 2010 | 21 |
| NCT00409175Amyloid Neuropathies, Familial · United States, Argentina, Brazil and more | 3 | Completed | May 2009 | 128 |
How it is read
Names in the registry
- “Tafamidis”, 19 entries
- “tafamidis”, 13 entries
- “Fx-1006A”, 6 entries
- “Tafamidis 61 mg free acid capsule (Reference)”, 2 entries
- “Tafamidis (Reference)”, 1 entry
Conditions, from the studies’ own filings
- Amyloid Neuropathies, Familial, 6 studies
- Cardiomyopathies, 2 studies
- Amyloidosis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.